rs779652673
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM1PP2PP3_StrongPP5_Very_Strong
The NM_001182.5(ALDH7A1):c.589C>T(p.Pro197Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,614,008 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001182.5 missense
Scores
Clinical Significance
Conservation
Publications
- pyridoxine-dependent epilepsyInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet, ClinGen
- pyridoxine-dependent epilepsy caused by ALDH7A1 mutantInheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALDH7A1 | NM_001182.5 | c.589C>T | p.Pro197Ser | missense_variant | Exon 6 of 18 | ENST00000409134.8 | NP_001173.2 | |
| ALDH7A1 | NM_001201377.2 | c.505C>T | p.Pro169Ser | missense_variant | Exon 6 of 18 | NP_001188306.1 | ||
| ALDH7A1 | NM_001202404.2 | c.589C>T | p.Pro197Ser | missense_variant | Exon 6 of 16 | NP_001189333.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ALDH7A1 | ENST00000409134.8 | c.589C>T | p.Pro197Ser | missense_variant | Exon 6 of 18 | 1 | NM_001182.5 | ENSP00000387123.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152120Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251478 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461888Hom.: 1 Cov.: 31 AF XY: 0.0000413 AC XY: 30AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152120Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74304 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Pyridoxine-dependent epilepsy Pathogenic:3
This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 197 of the ALDH7A1 protein (p.Pro197Ser). This variant is present in population databases (rs779652673, gnomAD 0.003%). This missense change has been observed in individual(s) with pyridoxine-dependent epilepsy (PMID: 20554659). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as c.505C>T, p.Pro169Ser. ClinVar contains an entry for this variant (Variation ID: 426363). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ALDH7A1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
- -
Variant summary: ALDH7A1 c.589C>T (p.Pro197Ser) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251478 control chromosomes (gnomAD). c.589C>T has been reported in the literature in multiple individuals affected with Pyridoxine-Dependent Epilepsy (e.g. Mills_2010, Oliveira_2013). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 20554659, 24184718). ClinVar contains an entry for this variant (Variation ID: 426363). Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 20554659, 32751059, 32956737, 31440721, 31302938, 30043187) -
Developmental and epileptic encephalopathy, 13 Pathogenic:1
- -
Seizure Pathogenic:1
- -
ALDH7A1-related disorder Pathogenic:1
The ALDH7A1 c.589C>T variant is predicted to result in the amino acid substitution p.Pro197Ser. This variant was reported in several individuals with pyridoxine-dependent epilepsy, some of which were reported with other deleterious variants in ALDH7A1 (Mills et al 2010. PubMed ID: 20554659; Coughlin et al. 2019. PubMed ID: 30043187; Truty et al. 2019. PubMed ID: 31440721). A functional assay measuring enzymatic activity showed reduced function with this variant compared to wild type (Laciak et al. 2019. PubMed ID: 31302938). This variant is reported in 0.0035% of alleles in individuals of European (non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at